Submission Details
| 510(k) Number | K223175 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 11, 2022 |
| Decision Date | March 10, 2023 |
| Days to Decision | 150 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K223175 is an FDA 510(k) clearance for the lntravascular Administration Sets with Stopcock and Manifold, a Stopcock, I.v. Set (Class II — Special Controls, product code FMG), submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on March 10, 2023, 150 days after receiving the submission on October 11, 2022. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K223175 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 11, 2022 |
| Decision Date | March 10, 2023 |
| Days to Decision | 150 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FMG — Stopcock, I.v. Set |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |